FdaApplication
ANDA 061334
Identifiers
- fda_app_no: ANDA061334
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | ANDA |
| approval_date | 1982-03-26 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BACTOCILL | OXACILLIN SODIUM | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| BACTOCILL | OXACILLIN SODIUM | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| BACTOCILL | OXACILLIN SODIUM | EQ 4GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| BACTOCILL | OXACILLIN SODIUM | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| BACTOCILL | OXACILLIN SODIUM | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
5 products